1. Getting the message across: a recent transporter structure shows the way. Henry LK, DeFelice LJ, Blakely RD (2006) Neuron 49(6): 791-6
    › Primary publication · 16543127 (PubMed)
  2. Dopamine signaling architecture in Caenorhabditis elegans. McDonald PW, Jessen T, Field JR, Blakely RD (2006) Cell Mol Neurobiol 26(4-6): 593-618
    › Primary publication · 16724276 (PubMed)
  3. Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. Miner LH, Jedema HP, Moore FW, Blakely RD, Grace AA, Sesack SR (2006) J Neurosci 26(5): 1571-8
    › Primary publication · 16452680 (PubMed) · PMC6675488 (PubMed Central)
  4. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, Gizer I, Teicher MH, Cohen BM, Robertson D, Waldman ID, Blakely RD, Kim KS (2006) Proc Natl Acad Sci U S A 103(50): 19164-9
    › Primary publication · 17146058 (PubMed) · PMC1748193 (PubMed Central)
  5. ADHD and the dopamine transporter: are there reasons to pay attention? Mazei-Robinson MS, Blakely RD (2006) Handb Exp Pharmacol (175): 373-415
    › Primary publication · 16722244 (PubMed)
  6. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. Meredith EJ, Holder MJ, Chamba A, Challa A, Drake-Lee A, Bunce CM, Drayson MT, Pilkington G, Blakely RD, Dyer MJ, Barnes NM, Gordon J (2005) FASEB J 19(9): 1187-9
    › Primary publication · 15870169 (PubMed)
  7. Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Hahn MK, Mazei-Robison MS, Blakely RD (2005) Mol Pharmacol 68(2): 457-66
    › Primary publication · 15894713 (PubMed)
  8. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD (2005) Neuropharmacology 49(6): 724-36
    › Primary publication · 16171832 (PubMed)
  9. Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins. Sung U, Jennings JL, Link AJ, Blakely RD (2005) Biochem Biophys Res Commun 333(3): 671-8
    › Primary publication · 15963952 (PubMed)
  10. Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells. Tomlinson ID, Mason JN, Blakely RD, Rosenthal SJ (2005) Methods Mol Biol : 51-60
    › Primary publication · 15923674 (PubMed)